Carcinoid Tumors Clinical Trials

• Study Evaluating SOM230 in Patients with Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00088595 - Active, not recruiting
  Carcinoid Tumors
  
• A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00328497 - Active, not recruiting
  Carcinoid Tumor
  
• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00027638 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00093782 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
  ClinicalTrials.gov Identifier: NCT00412061 - Recruiting
  Carcinoid Tumor; Malignant Carcinoid Syndrome
  
• Study of SU011248 in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00056693 - Active, not recruiting
  Neuroendocrine Tumor; Carcinoid Tumor
  
• BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074256 - Recruiting
  adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
  
• Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00002470 - Completed
  metastatic gastrointestinal carcinoid tumor; recurrent gastrointestinal carcinoid tumor; pulmonary carcinoid tumor
  
• EPO906 in Carcinoid and other Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00050349 - Suspended
  Carcinoid; Neuroendocrine Tumors
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00055809 - Completed
  recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416767 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00466856 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Neoplastic Syndrome; Pheochromocytoma
  
• Flavopiridol in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00112684 - Recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; Pheochromocytoma; Thyroid Cancer
  
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003597 - Active, not recruiting
  Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227617 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Carcinoma of the Skin
  
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
  
• Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00454376 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neoplastic Syndrome
  
• AMG 706 in Treating Patients With Low-Grade Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00427349 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00580320 - Recruiting
  Melanoma; Soft Tissue Sarcoma; Parathyroid Carcinoma; Small Cell Carcinoma of the Lung; Carcinoid Tumors
  
• Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436735 - Recruiting
  Colorectal Cancer; Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neuroendocrine Carcinoma of the Skin; Ovarian Cancer; Pheochromocytoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
  ClinicalTrials.gov Identifier: NCT00227136 - Terminated
  Carcinoid Tumors; Neuroendocrine Tumors
  
• Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002516 - Active, not recruiting
  metastatic tumors of the Ewing's family; localized tumors of the Ewing's family
  
• Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
  ClinicalTrials.gov Identifier: NCT00042367 - Active, not recruiting
  Brain Tumors
  
• Study Evaluating AMG 706 in Subjects with Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00093873 - Active, not recruiting
  Tumors
  
• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00024076 - Active, not recruiting
  lung metastases; malignant mesothelioma; Non-small cell lung cancer; pulmonary carcinoid tumor; Small Cell Lung Cancer; thymoma and thymic carcinoma
  
• Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
  ClinicalTrials.gov Identifier: NCT00187174 - Recruiting
  Tumors; Brain Tumors; Rhabdomyosarcoma; Sarcoma, Soft Tissue
  
• Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00085878 - Active, not recruiting
  Solid Tumors
  
• A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00259935 - Active, not recruiting
  Tumors
  
• NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors
  ClinicalTrials.gov Identifier: NCT00299728 - Active, not recruiting
  Tumors
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00373490 - Active, not recruiting
  Tumors
  
• Safety Assessment of One-Hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00292864 - Active, not recruiting
  Tumors
  
• Study of E7389 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00326950 - Active, not recruiting
  Tumors
  
• Surgery Plus Radiation Therapy With and Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
  ClinicalTrials.gov Identifier: NCT00003859 - Active, not recruiting
  untreated childhood supratentorial primitive neuroectodermal and pineal tumors; ...
  
• Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
  ClinicalTrials.gov Identifier: NCT00477503 - Active, not recruiting
  Central Nervous System Tumors; Brain Tumors
  
• Safety and Exploratory Biomarker Trial in Relapsed/Refractory Pediatric Solid Tumors
  ClinicalTrials.gov Identifier: NCT00106353 - Recruiting
  Tumors
  
• A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
  ClinicalTrials.gov Identifier: NCT00187226 - Recruiting
  Central Nervous System Tumors; Brain Tumors
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00127127 - Active, not recruiting
  Tumors
  
• SB-715992 in Combination with Capecitabine in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00119171 - Active, not recruiting
  Tumors
  
• Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00048984 - Recruiting
  localized tumors of the Ewing's family; metastatic tumors of the Ewing's family; recurrent tumors of the Ewing's family
  
• Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00069277 - Active, not recruiting
  Advanced Solid Tumors
  
• Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00201812 - Active, not recruiting
  Tumors
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00281905 - Active, not recruiting
  Brain and Central Nervous System Tumors; Neuroblastoma
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain
  ClinicalTrials.gov Identifier: NCT00293358 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Diagnostic Imaging in Children With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00019292 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00313521 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.
  ClinicalTrials.gov Identifier: NCT00298779 - Active, not recruiting
  Tumors; Non-Hodgkins's Lymphoma
  
• Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
  ClinicalTrials.gov Identifier: NCT00547131 - Recruiting
  Brain and Central Nervous System Tumors
  
• Phase I Trial of ZIO-101 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00509782 - Active, not recruiting
  Solid Tumors
  
• ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
  ClinicalTrials.gov Identifier: NCT00339131 - Completed
  Pheochromocytoma; Paraganglioma; Carcinoid
  
• Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
  ClinicalTrials.gov Identifier: NCT00544284 - Recruiting
  Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00017199 - Completed
  miscellaneous islet cell cancer; Gastrinoma; Insulinoma; Somatostatinoma; Glucagonoma; metastatic gastrointestinal carcinoid tumor
  
• A Case-Referent Study of Brain Tumors in Adults
  ClinicalTrials.gov Identifier: NCT00339300 - Active, not recruiting
  Brain Tumors
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00360854 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
  ClinicalTrials.gov Identifier: NCT00171977 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00412503 - Recruiting
  Refractory Tumors; Malignant Tumors
  
• Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
  ClinicalTrials.gov Identifier: NCT00062205 - Active, not recruiting
  recurrent tumors of the Ewing's family
  
• Open-Label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00293124 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00394446 - Active, not recruiting
  Refractory Solid Tumors
  
• Pemetrexed in Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00424723 - Active, not recruiting
  Neuroendocrine Tumors
  
• Study Evaluating CMD-193 in Advanced Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00161642 - Active, not recruiting
  Advanced Malignant Tumors
  
• Phase I Trial of G3139 Plus Chemotherapy to Treat Relapsed Childhood Tumors
  ClinicalTrials.gov Identifier: NCT00061191 - Recruiting
  Tumors
  
• A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00419328 - Active, not recruiting
  Advanced Solid Tumors
  
• Chemotherapy with Hematopoietic Stem Cell Support for Children with High Risk Solid Tumors and Lymphomas
  ClinicalTrials.gov Identifier: NCT00152126 - Active, not recruiting
  Neuroblastoma; Central Nervous System Tumors; Lymphomas; Wilms Tumor
  
• A Phase 1 Study of S-3304 in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00033215 - Active, not recruiting
  Solid Tumors
  
• SB-743921 In Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00136513 - Active, not recruiting
  Solid Tumors
  
• Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
  ClinicalTrials.gov Identifier: NCT00027716 - Active, not recruiting
  adult soft tissue sarcoma; metastatic osteosarcoma; metastatic tumors of the Ewing's family; Osteosarcoma; tumors of the Ewing's family
  
• Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
  ClinicalTrials.gov Identifier: NCT00276783 - Recruiting
  Adult Astrocytic Tumors; Adult Brain Tumor; Adult Oligodendroglial Tumors; Adult Tumors Metastatic to Brain; Mixed Gliomas; ...
  
• Role of Glivec in Patients with Tumor Cells Positive for c-Kit or PDGFR; a Multi Center Study.
  ClinicalTrials.gov Identifier: NCT00159016 - Active, not recruiting
  Metastatic solid tumors.
  
• Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00238173 - Active, not recruiting
  Bone Marrow Suppression; Brain and Central Nervous System Tumors; Drug Toxicity; Long-Term Effects Secondary to Cancer Therapy in Children
  
• Ketoconazole Administration on How It is Affects the Body and Broken Down and How It Acts on the Body When Used with VELCADE
  ClinicalTrials.gov Identifier: NCT00129207 - Active, not recruiting
  Advanced Solid Tumors
  
• A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients with Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00165802 - Recruiting
  Cancer, malignant tumors
  
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00201734 - Recruiting
  Tumors; Unknown Primary Tumors; Adenocarcinoma
  
• Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
  ClinicalTrials.gov Identifier: NCT00412789 - Recruiting
  Tumors
  
• Study of Oral CNF2024 in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00345189 - Recruiting
  Tumors; Lymphoma
  
• Dose Escalation Study of SH U04722 in Solid Tumors
  ClinicalTrials.gov Identifier: NCT00375453 - Recruiting
  Tumors
  
• Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00382733 - Recruiting
  Tumors
  
• Cilengitide in Treating Children With Refractory Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00063973 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood spinal cord tumors
  
• Tandem PBSC Rescue for High Risk Solid Tumors
  ClinicalTrials.gov Identifier: NCT00179816 - Recruiting
  Neuroectodermal Tumors, Primitive
  
• One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00358397 - Recruiting
  Tumors
  
• Study of BMS-354825 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00339144 - Recruiting
  Tumors
  
• Study of PXD101 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00413075 - Recruiting
  Tumors
  
• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
  ClinicalTrials.gov Identifier: NCT00003515 - Active, not recruiting
  metastatic childhood soft tissue sarcoma; recurrent childhood soft tissue sarcoma; metastatic tumors of the Ewing's family; ...
  
• A Study of the Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors That Are Non-Curable With Standard Therapy
  ClinicalTrials.gov Identifier: NCT00402415 - Recruiting
  Tumors
  
• A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00422682 - Recruiting
  Tumors
  
• Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00395434 - Recruiting
  Tumors
  
• A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00397046 - Recruiting
  Tumors
  
• A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00400023 - Recruiting
  Tumors
  
• High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
  ClinicalTrials.gov Identifier: NCT00180791 - Recruiting
  Medulloblastoma; Brain Tumors; Neuroectodermal Tumors, Primitive
  
• A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00276913 - Active, not recruiting
  Advanced or Metastatic Solid Tumors
  
• A First in Human Dose Escalation Study Evaluating the Safety and Kinetics of BSI-201 in Subjects With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00298675 - Recruiting
  Tumors
  
• A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00495144 - Recruiting
  Tumors; Hypoxia
  
• Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00276718 - Active, not recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer
  
• Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
  ClinicalTrials.gov Identifier: NCT00276770 - Recruiting
  Adult Astrocytic Tumors; Adult Brain Stem Glioma; Adult Brain Tumor; Adult Ependymal Tumors; Adult Oligodendroglial Tumors; Mixed Gliomas
  
• Safety Study of AP23573 in Patients with Advanced, Refractory or Recurrent Malignancies
  ClinicalTrials.gov Identifier: NCT00060645 - Active, not recruiting
  Tumors; Lymphoma; Multiple Myeloma